EP3256479
4-setin bensoxabóról efnasambönd og notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.2.2016EP published:
29.7.2020EP application number:
16706002.9
EP translation filed:
17.9.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
11.2.2036Expiry date:
11.2.2026Next due date:
28.2.2026
Title:
4 -SUBSTITUTED BENZOXABOROLE COMPOUNDS AND USES THEREOF
Timeline
Today
12.2.2016EP application
29.7.2020EP Publication
17.9.2020Translation submitted
15.10.2020Registration published
11.2.2026Expires
Owner
Name:
GlaxoSmithKline Intellectual Property (No. 2) LimitedAddress:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, GB
Name:
Anacor Pharmaceuticals, Inc.Address:
1020 East Meadow Circle, Palo Alto, CA 94303, US
Inventor
Name:
ALEMPARTE-GALLARDO, CarlosAddress:
28760 Tres Cantos (Madrid), ES
Name:
ALLEY, M.R.K. (dickon)Address:
Palo Alto, California 94303, US
Name:
BARROS-AGUIRRE, DavidAddress:
28760 Tres Cantos (Madrid), ES
Name:
GIORDANO, IlariaAddress:
28760 Tres Cantos (Madrid), ES
Name:
HERNANDEZ, VincentAddress:
Palo Alto, California 94303, US
Name:
LI, XianfengAddress:
Palo Alto, California 94303, US
Name:
PLATTNER, Jacob J.Address:
Palo Alto, California 94303, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15382054Date:
12.2.2015Country:
EP
Number:
15382055Date:
12.2.2015Country:
EP
Number:
15382056Date:
12.2.2015Country:
EP
Classification
Categories:
C07F 5/02, A61P 31/06, A61K 31/69
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 13.1.2021
Expires: 11.2.2022
Payer: Örn Þór slf.
Number: 7
Paid: 19.1.2022
Expires: 11.2.2023
Payer: Patice ehf.
Number: 8
Paid: 19.1.2023
Expires: 11.2.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.1.2024
Expires: 11.2.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.1.2024
Expires: 11.2.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.1.2025
Expires: 11.2.2026
Payer: Árnason Faktor ehf.